Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial. Sato Y, Yamashita H, Yagi K, Nomura S, et al. Anticancer Res 2024;44:3125-3131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sato Y, Yamashita H, Yagi K, Nomura S, et al. Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial. Anticancer Res 2024;44:3125-3131.
PMID: 38925825